BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Witz IP. Tumor-Microenvironment Interactions. In: Dalgleish AG, Haefner B, editors. The Link Between Inflammation and Cancer. Boston: Springer US; 2006. pp. 125-40. [DOI: 10.1007/0-387-26283-0_6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Reichardt NC, Martín-Lomas M, Penadés S. Opportunities for glyconanomaterials in personalized medicine. Chem Commun (Camb) 2016;52:13430-9. [PMID: 27709147 DOI: 10.1039/c6cc04445j] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 3.8] [Reference Citation Analysis]
2 Liu CJ, Liu TY, Kuo LT, Cheng HW, Chu TH, Chang KW, Lin SC. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. J Pathol 2008;214:489-97. [PMID: 18213732 DOI: 10.1002/path.2306] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
3 Tvaroška I. Glycosyltransferases as targets for therapeutic intervention in cancer and inflammation: molecular modeling insights. Chem Pap . [DOI: 10.1007/s11696-021-02026-7] [Reference Citation Analysis]
4 Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, Lopes MA, Kowalski LP, Coletta RD. Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 2008;44:509-17. [PMID: 17826300 DOI: 10.1016/j.oraloncology.2007.07.001] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 6.5] [Reference Citation Analysis]
5 Maru GB, Gandhi K, Ramchandani A, Kumar G. The Role of Inflammation in Skin Cancer. In: Aggarwal BB, Sung B, Gupta SC, editors. Inflammation and Cancer. Basel: Springer; 2014. pp. 437-69. [DOI: 10.1007/978-3-0348-0837-8_17] [Cited by in Crossref: 67] [Cited by in F6Publishing: 56] [Article Influence: 8.4] [Reference Citation Analysis]
6 Cohen IR. Real and artificial immune systems: computing the state of the body. Nat Rev Immunol 2007;7:569-74. [DOI: 10.1038/nri2102] [Cited by in Crossref: 75] [Cited by in F6Publishing: 48] [Article Influence: 5.0] [Reference Citation Analysis]
7 Madsen CD, Sahai E. Cancer dissemination--lessons from leukocytes. Dev Cell 2010;19:13-26. [PMID: 20643347 DOI: 10.1016/j.devcel.2010.06.013] [Cited by in Crossref: 133] [Cited by in F6Publishing: 116] [Article Influence: 11.1] [Reference Citation Analysis]
8 Aychek T, Miller K, Sagi-assif O, Levy-nissenbaum O, Israeli-amit M, Pasmanik-chor M, Jacob-hirsch J, Amariglio N, Rechavi G, Witz IP. E-selectin regulates gene expression in metastatic colorectal carcinoma cells and enhances HMGB1 release. Int J Cancer 2008;123:1741-50. [DOI: 10.1002/ijc.23375] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
9 Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, Lopes MA, Nishimoto I, Kowalski LP, Coletta RD. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 2007;51:849-53. [PMID: 18042073 DOI: 10.1111/j.1365-2559.2007.02873.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 86] [Article Influence: 5.6] [Reference Citation Analysis]
10 Patil N, Allgayer H, Leupold JH. MicroRNAs in the Tumor Microenvironment. Adv Exp Med Biol 2020;1277:1-31. [PMID: 33119862 DOI: 10.1007/978-3-030-50224-9_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pockley AG, Vaupel P, Multhoff G. NK cell-based therapeutics for lung cancer. Expert Opin Biol Ther 2020;20:23-33. [PMID: 31714156 DOI: 10.1080/14712598.2020.1688298] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
12 Sung SY, Hsieh CL, Wu D, Chung LW, Johnstone PA. Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance. Curr Probl Cancer. 2007;31:36-100. [PMID: 17362788 DOI: 10.1016/j.currproblcancer.2006.12.002] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 5.2] [Reference Citation Analysis]
13 Witz IP. The selectin–selectin ligand axis in tumor progression. Cancer Metastasis Rev 2008;27:19-30. [DOI: 10.1007/s10555-007-9101-z] [Cited by in Crossref: 99] [Cited by in F6Publishing: 91] [Article Influence: 7.1] [Reference Citation Analysis]
14 Mimeault M, Batra SK. Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications. Cancer Metastasis Rev 2007;26:203-14. [PMID: 17273942 DOI: 10.1007/s10555-007-9052-4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]